- Home
- SKYE vs ESP Comparison
SKYE vs ESP Comparison
Compare SKYE & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- ESP
- Stock Information
- Founded
- SKYE 2012
- ESP 1928
- Country
- SKYE United States
- ESP United States
- Employees
- SKYE N/A
- ESP N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- ESP Industrial Machinery/Components
- Sector
- SKYE Health Care
- ESP Technology
- Exchange
- SKYE Nasdaq
- ESP Nasdaq
- Market Cap
- SKYE 80.7M
- ESP 84.1M
- IPO Year
- SKYE N/A
- ESP N/A
- Fundamental
- Price
- SKYE $1.81
- ESP $31.30
- Analyst Decision
- SKYE Buy
- ESP
- Analyst Count
- SKYE 6
- ESP 0
- Target Price
- SKYE $16.60
- ESP N/A
- AVG Volume (30 Days)
- SKYE 1.7M
- ESP 14.8K
- Earning Date
- SKYE 05-08-2025
- ESP 05-20-2025
- Dividend Yield
- SKYE N/A
- ESP 3.20%
- EPS Growth
- SKYE N/A
- ESP 31.14
- EPS
- SKYE N/A
- ESP 2.45
- Revenue
- SKYE N/A
- ESP $43,917,522.00
- Revenue This Year
- SKYE N/A
- ESP N/A
- Revenue Next Year
- SKYE N/A
- ESP N/A
- P/E Ratio
- SKYE N/A
- ESP $12.78
- Revenue Growth
- SKYE N/A
- ESP 18.62
- 52 Week Low
- SKYE $1.14
- ESP $20.20
- 52 Week High
- SKYE $13.49
- ESP $33.00
- Technical
- Relative Strength Index (RSI)
- SKYE 48.48
- ESP 63.23
- Support Level
- SKYE $1.36
- ESP $30.30
- Resistance Level
- SKYE $2.30
- ESP $31.65
- Average True Range (ATR)
- SKYE 0.21
- ESP 0.85
- MACD
- SKYE 0.02
- ESP 0.00
- Stochastic Oscillator
- SKYE 42.35
- ESP 86.33
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.